ACHIEVE LIFE SCIENCES, INC. — Investor Relations & Filings
Filings indexed
1,014
across all filing types
Latest filing
2009-05-28
Director's Dealing
Country
US
United States of America
Listing
US
ACHV
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| MAIN DOCUMENT DESCRIPTION | 2009-05-28 | English | |
| FORM 8-K | 2009-05-18 | English | |
| FORM 4 SUBMISSION | 2009-05-13 | English | |
| FORM 4 SUBMISSION | 2009-05-13 | English | |
| FORM 4 SUBMISSION | 2009-05-13 | English | |
| FORM 4 SUBMISSION | 2009-05-13 | English |
Browse filings by year
19 years- 2026 13 filings
- 2025 54 filings
- 2024 63 filings
- 2023 65 filings
- 2022 58 filings
- 2021 40 filings
- 2020 60 filings
- 2019 70 filings
- 2018 56 filings
- 2017 83 filings
- 2016 44 filings
- 2015 44 filings
- 2014 46 filings
- 2013 46 filings
- 2012 46 filings
- 2011 28 filings
- 2010 81 filings
- 2009 61 filings
- 2008 55 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2009
15 filings
| |||||
| 10591232 | MAIN DOCUMENT DESCRIPTION | 2009-05-28 | English | ||
| 10591104 | FORM 8-K | 2009-05-18 | English | ||
| 10591117 | FORM 4 SUBMISSION | 2009-05-13 | English | ||
| 10591130 | FORM 4 SUBMISSION | 2009-05-13 | English | ||
| 10591107 | FORM 4 SUBMISSION | 2009-05-13 | English | ||
| 10591110 | FORM 4 SUBMISSION | 2009-05-13 | English | ||
| 10591112 | FORM 4 SUBMISSION | 2009-05-13 | English | ||
| 10591113 | FORM 10-Q | 2009-05-07 | English | ||
| 10591115 | FORM 8-K | 2009-05-07 | English | ||
| 10591131 | FORM 8-K | 2009-04-29 | English | ||
| 10591116 | BDC CAPITAL INC. | 2009-04-28 | English | ||
| 10591250 | Regulatory Filings 2009 | 2009-04-15 | English | ||
| 10591119 | DEF 14A | 2009-04-13 | English | ||
| 10591120 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 2009-04-08 | English | ||
| 10591132 | FORM 8-K | 2009-04-01 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ACHIEVE LIFE SCIENCES, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33882/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33882 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33882 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33882 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33882}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACHIEVE LIFE SCIENCES, INC. (id: 33882)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.